KORU Medical Systems, Inc. Common Stock (DE) (KRMD) — 分析摘要
KORU Medical Systems, Inc. Common Stock (DE)（KRMD）的市值为187.41百万美元，最近一年的营收同比增长了+22.2%。净利润率为-6.4%。当前市盈率为-82.2倍。
核心要点
- 营收同比变化+22.2%
- 净利润率-6.4%
- 市盈率-82.2倍
与SURGICAL & MEDICAL INSTRUMENTS & APPARATUS板块的其他公司相比，KRMD的营收增长为+22.2%，市盈率为-82.2倍。
KORU Medical Systems, Inc. Common Stock (DE) (KRMD)
更新 — ET · 来源 POLYGON
红旗与风险提示无重大红旗
基于最新财报，没有触发重大的信用、利润率或趋势红旗。
KORU Medical Systems Inc develops, manufactures, and commercializes large volume subcutaneous infusion solutions for the subcutaneous drug delivery market. Its product portfolio focuses on mechanical infusion devices, including the FREEDOM60 and FreedomEdge syringe drivers, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company operates as one segment. Its revenue streams are: Domestic Core, International Core and Pharma services and clinical trials. The majority of the company's revenue is derived from the Domestic Core business, which consists of sales of its syringe drivers, tubing and needles. Geographically, its revenues are predominantly derived from the United States.
行业
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
员工人数
73
总部
MAHWAH, NJ
Exchange
XNAS
基于 4 年财务数据的系统性竞争优势评估
此评估基于历史财务数据的量化分析，不构成投资建议。护城河评级可能随行业和竞争环境变化。
首版展示近期 SEC Forms 3、4、5 备案活动。尚未解析单笔买入/卖出交易。
资本结构
现金流
免责声明：本站内容不构成投资建议。数据来源于SEC EDGAR和Polygon.io。过往业绩不代表未来表现。投资决策前请自行研究。